Investigator

Investigator - Axcellant

Investigator

  1. Feb 28, 2025

What Does the ‘Investigator’ Mean?

An investigator in clinical research refers to a qualified individual who is responsible for conducting a clinical trial at a research site. This person is typically a medical doctor or healthcare professional with the necessary expertise to oversee the study and ensure it adheres to the protocol, regulatory requirements, and ethical standards.

The investigator’s primary duties include recruiting and screening participants, administering the investigational treatment, collecting data, and reporting results to the sponsor. They also play a crucial role in safeguarding the rights, safety, and well-being of study participants throughout the clinical trial process.

Why Is the ‘Investigator’ Important in Clinical Research?

The term ‘investigator’ is crucial in clinical research as it designates the key individual responsible for the scientific integrity and ethical conduct of a clinical trial. Investigators play a pivotal role in ensuring that studies are carried out according to regulatory guidelines and good clinical practice standards, which is essential for generating reliable and valid data.

Furthermore, investigators serve as the primary point of contact between study participants, sponsors, and regulatory authorities. Their expertise and oversight are critical in managing potential risks, addressing unforeseen issues, and maintaining the overall quality and credibility of clinical research endeavors.

Good Practices and Procedures

  1. Maintain comprehensive documentation of all study-related activities, including detailed source records and timely completion of case report forms.
  2. Establish a robust system for adverse event monitoring and reporting, ensuring prompt communication with the sponsor and ethics committee.
  3. Implement regular internal quality control checks to verify data accuracy and protocol compliance before external audits.
  4. Develop and maintain clear delegation logs, ensuring all study team members are appropriately trained and qualified for their assigned tasks.
  5. Conduct periodic review meetings with the study team to address challenges, share best practices, and maintain consistent protocol interpretation.

Related Terms

Resources

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…

From Half-Life to Clinical Impact: Mastering Time-Critical Supply Chains

How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…